Literature DB >> 18687394

High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.

Haihua Shu1, Masakazu Hayashida, Hideko Arita, Wenqi Huang, Liangshan Xiao, Shunsuke Chiba, Hiroshi Sekiyama, Kazuo Hanaoka.   

Abstract

AIM OF THE STUDY: In this study, we investigated the effects of processed Aconiti tuber (PAT), an oriental herbal medicine, at analgesic doses on acute morphine antinociception in morphine-naïve mice and morphine tolerance in morphine-tolerant mice.
MATERIALS AND METHODS: In acute experiments, mice received subcutaneous (s.c.) morphine (2, 5, or 10 mg/kg) and oral distilled water or PAT (0.3, 1.0, or 3.0 g/kg). The mechanical nociceptive threshold (MNT) and thermal nociceptive latency (TNL) were measured with the tail pressure test and tail flick test, respectively, before, and at 30, 60, 90, and 120 min after s.c. morphine injection. In chronic experiments, mice received s.c. morphine (10 mg/kg) and oral distilled water or PAT (0.3, 1.0, or 3.0 g/kg) once daily for 11 days. MNT was measured before, and at 60 min after, and TNL was measured before, and at 30 min after, daily morphine injections on days 1-11.
RESULTS: PAT at analgesic doses inhibited the acute antinociceptive effect of morphine dose-dependently in morphine-naïve mice. In contrast, PAT at analgesic doses potentiated the chronic antinociceptive effect of morphine dose-dependently by inhibiting the development of morphine tolerance dose-dependently. These effects of PAT on acute and chronic morphine antinociception were mediated through activation of kappa-opioid receptors.
CONCLUSIONS: These results indicated that chronic co-administration of PAT at analgesic doses with morphine could provide better-maintained morphine analgesia in a long-term morphine treatment after initial inhibition of acute morphine antinociception for a brief period of time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687394     DOI: 10.1016/j.jep.2008.07.009

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  1 in total

1.  Ignavine: a novel allosteric modulator of the μ opioid receptor.

Authors:  Katsuya Ohbuchi; Chika Miyagi; Yasuyuki Suzuki; Yasuharu Mizuhara; Keita Mizuno; Yuji Omiya; Masahiro Yamamoto; Eiji Warabi; Yuka Sudo; Akinobu Yokoyama; Kanako Miyano; Takatsugu Hirokawa; Yasuhito Uezono
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.